EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY-NC-ND 4.0

Rapid progress in molecular targeted therapy for allergic diseases

Hiroyuki Nagase

Allergology International · 2023

DOI: 10.1016/j.alit.2022.11.011 ↗

Kurz gefasst

Editorial in der Zeitschrift Allergology International, 2023. Verfasst von Hiroyuki Nagase. Beteiligte Einrichtung: Division of Respiratory Medicine and Allergology, Department of Medicine, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-Ku, Tokyo 173-8…. Hauptthemen laut MEDLINE: Molecular Targeted Therapy, Hypersensitivity. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Targeted TherapyHypersensitivityHumans

Autor:innen und Institutionen

  • Division of Respiratory Medicine and Allergology, Department of Medicine, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-Ku, Tokyo 173-8606, Japan. Electronic address: nagaseh@med.teikyo-u.ac.jp.

Zitieren

APA

Nagase, H. (2023). Rapid progress in molecular targeted therapy for allergic diseases. Allergology International. https://doi.org/10.1016/j.alit.2022.11.011

Vancouver

Nagase H. Rapid progress in molecular targeted therapy for allergic diseases. Allergology International. 2023. doi:10.1016/j.alit.2022.11.011

BibTeX
@article{Nagase2023,
  author = {Nagase, Hiroyuki},
  title = {Rapid progress in molecular targeted therapy for allergic diseases},
  journal = {Allergology International},
  year = {2023},
  doi = {10.1016/j.alit.2022.11.011}
}
Kostenlos starten →